These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12519376)

  • 41. Myotonia congenita and myotonic dystrophy in the same family: coexistence of a CLCN1 mutation and expansion in the CNBP (ZNF9) gene.
    Sun C; Van Ghelue M; Tranebjærg L; Thyssen F; Nilssen Ø; Torbergsen T
    Clin Genet; 2011 Dec; 80(6):574-80. PubMed ID: 21204798
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Type 2 myotonic dystrophy can be predicted by the combination of type 2 muscle fiber central nucleation and scattered atrophy.
    Bassez G; Chapoy E; Bastuji-Garin S; Radvanyi-Hoffman H; Authier FJ; Pellissier JF; Eymard B; Gherardi RK
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):319-25. PubMed ID: 18379436
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of a single nucleotide polymorphism in the ZNF9 gene and analysis of association with myotonic dystrophy type II (DM2) in the Italian population.
    Vallo L; Bonifazi E; Borgiani P; Novelli G; Botta A
    Mol Cell Probes; 2005 Feb; 19(1):71-4. PubMed ID: 15652222
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of the [CCTG]n repeat expansion on ZNF9 expression in myotonic dystrophy type II (DM2).
    Botta A; Caldarola S; Vallo L; Bonifazi E; Fruci D; Gullotta F; Massa R; Novelli G; Loreni F
    Biochim Biophys Acta; 2006 Mar; 1762(3):329-34. PubMed ID: 16376058
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myotonic dystrophies: An update on clinical aspects, genetic, pathology, and molecular pathomechanisms.
    Meola G; Cardani R
    Biochim Biophys Acta; 2015 Apr; 1852(4):594-606. PubMed ID: 24882752
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Visualization of double-stranded RNAs from the myotonic dystrophy protein kinase gene and interactions with CUG-binding protein.
    Michalowski S; Miller JW; Urbinati CR; Paliouras M; Swanson MS; Griffith J
    Nucleic Acids Res; 1999 Sep; 27(17):3534-42. PubMed ID: 10446244
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Musculoskeletal pain in patients with myotonic dystrophy type 2.
    George A; Schneider-Gold C; Zier S; Reiners K; Sommer C
    Arch Neurol; 2004 Dec; 61(12):1938-42. PubMed ID: 15596616
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tackling the pathogenesis of RNA nuclear retention in myotonic dystrophy.
    Mastroyiannopoulos NP; Shammas C; Phylactou LA
    Biol Cell; 2010 Jul; 102(9):515-23. PubMed ID: 20690904
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proximal myotonic myopathy: clinical, electrophysiological and pathological findings in a family.
    Kohler A; Burkhard P; Hefft S; Bottani A; Pizzolato GP; Magistris MR
    Eur Neurol; 2000; 43(1):50-3. PubMed ID: 10601809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A pedigree with myotonic dystrophy: non-CTG, non-CCTG repeat expansion].
    Zhao XP; Xie HJ; Zheng HM; Yu ZL; Cui Y; Ding SJ; Ren DM; Tang GM
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Oct; 21(5):459-62. PubMed ID: 15476170
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of the innate immune response and interferon signalling in myotonic dystrophy type 1 and type 2 cataracts.
    Rhodes JD; Lott MC; Russell SL; Moulton V; Sanderson J; Wormstone IM; Broadway DC
    Hum Mol Genet; 2012 Feb; 21(4):852-62. PubMed ID: 22062891
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Getting a grip on the myotonic dystrophies.
    Thornton CA; Ashizawa T
    Neurology; 1999 Jan; 52(1):12-3. PubMed ID: 9921841
    [No Abstract]   [Full Text] [Related]  

  • 53. Creatine monohydrate in DM2/PROMM: a double-blind placebo-controlled clinical study. Proximal myotonic myopathy.
    Schneider-Gold C; Beck M; Wessig C; George A; Kele H; Reiners K; Toyka KV
    Neurology; 2003 Feb; 60(3):500-2. PubMed ID: 12578937
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular therapy in myotonic dystrophy: focus on RNA gain-of-function.
    Mulders SA; van Engelen BG; Wieringa B; Wansink DG
    Hum Mol Genet; 2010 Apr; 19(R1):R90-7. PubMed ID: 20406734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical aspects of myotonic dystrophy in childhood].
    Osawa M; Inoko K; Muto A
    No To Hattatsu; 2009 May; 41(3):163-70. PubMed ID: 19517784
    [No Abstract]   [Full Text] [Related]  

  • 56. The germinal center kinase gene and a novel CDC25-like gene are located in the vicinity of the PYGM gene on 11q13.
    Kedra D; Seroussi E; Fransson I; Trifunovic J; Clark M; Lagercrantz J; Blennow E; Mehlin H; Dumanski J
    Hum Genet; 1997 Oct; 100(5-6):611-9. PubMed ID: 9341881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Homozygosity for CCTG mutation in myotonic dystrophy type 2.
    Schoser BG; Kress W; Walter MC; Halliger-Keller B; Lochmüller H; Ricker K
    Brain; 2004 Aug; 127(Pt 8):1868-77. PubMed ID: 15231584
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice.
    Roberts R; Timchenko NA; Miller JW; Reddy S; Caskey CT; Swanson MS; Timchenko LT
    Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13221-6. PubMed ID: 9371827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy.
    Philips AV; Timchenko LT; Cooper TA
    Science; 1998 May; 280(5364):737-41. PubMed ID: 9563950
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation.
    Justice RW; Zilian O; Woods DF; Noll M; Bryant PJ
    Genes Dev; 1995 Mar; 9(5):534-46. PubMed ID: 7698644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.